Health Condition 1: O80- Encounter for full-term uncomplicated delivery
Conditions
Interventions
Intervention1: Carbetocin: 100 mcg intravenously over 1 minute without dilution
Control Intervention1: Oxytocin: Oxytocin 5 units in 5 ml normal saline intravenously,10 units of Oxytocin intramuscular
Sponsors
RAJAGIRI HOSPITAL
Eligibility
Inclusion criteria
Inclusion criteria: ALL WOMEN UNDERGOING VAGINAL DELIVERIES INCLUDING INSTRUMENTAL DELIVERIES AT RAJAGIRI HOSPITAL DURING THE STUDY PERIOD
Exclusion criteria
Exclusion criteria: HEPATIC OR RENAL DISEASES SERIOUS CARDIOVASCULAR DISEASES EPILEPSY BLEEDING DIATHESIS
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Compare the mean blood loss ,frequency of cases with blood loss more than 500 ml, drop in Hemoglobin, number of cases requiring additional uterotonic agents has to be used, the occurence of postpartum hemorrhage in both groups, the requirement of blood transfusion between the Carbetocin and Oxytocin groupsTimepoint: 4 Weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| ââ?¬Â¢ To compare the side effect profile of both the drugs including nausea, vomiting, hypotension, dizziness and manual removal of the placentaTimepoint: 4 WEEKS | — |
Countries
India
Contacts
Public ContactDrJOSHY JOSEPH NEELANKAVIL
RAJAGIRI HOSPITAL
Outcome results
None listed